Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Acquires Cerilliant

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced Thursday after the close of the market that it has purchased all outstanding shares of Cerilliant, a Texas-based analytical reference standards firm, for an undisclosed amount.

The deal strengthens Sigma-Aldrich's analytical chemistry product portfolio and brings to it more than 2,800 products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic, and clinical toxicology markets, the St. Louis-based research products and chemicals firm said in a statement.

Sigma-Aldrich said that the acquisition is anticipated to be neutral to mildly accretive to earnings per share for 2011.

"Their experienced team and capabilities, combined with the quality and breadth of our current analytical brands, our broad scientific knowledge and our powerful global footprint will provide analytical customers around the globe with access to a broad and ever-increasing range of specialized, high-quality analytical standards from a convenient and reliable single source," Russel Gant, VP of the analytical research business at Sigma-Aldrich, said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.